{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ambisome&page=2", "query": { "intervention": "Ambisome", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ambisome&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T16:31:31.929Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00161356", "title": "Ambisome in Liver Transplant Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Liver Transplantation" ], "interventions": [ { "name": "Ambisome", "type": "DRUG" }, { "name": "Liver Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 10, "start_date": "2005-09", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-06-23", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00161356" }, { "nct_id": "NCT05101187", "title": "Olorofim Aspergillus Infection Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Invasive Aspergillosis" ], "interventions": [ { "name": "Olorofim", "type": "DRUG" }, { "name": "AmBisome®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "F2G Biotech GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 225, "start_date": "2022-03-31", "completion_date": "2026-11-01", "has_results": false, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Duarte, California • Sacramento, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05101187" }, { "nct_id": "NCT00491426", "title": "Antimicrobial PK in Infants With Suspected or Confirmed Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Infection" ], "interventions": [ { "name": "Ampicillin", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Piperacillin/Tazobactam", "type": "DRUG" }, { "name": "Acyclovir", "type": "DRUG" }, { "name": "Amphotericin B", "type": "DRUG" }, { "name": "Ambisome", "type": "DRUG" }, { "name": "Anidulafungin", "type": "DRUG" }, { "name": "Caspofungin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "120 Days", "sex": "ALL", "summary": "Up to 120 Days" }, "enrollment_count": 450, "start_date": "2006-01", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2012-11-19", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 6, "location_summary": "La Jolla, California • Washington D.C., District of Columbia • Louisville, Kentucky + 3 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00491426" }, { "nct_id": "NCT00012467", "title": "Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis, Cryptococcal", "HIV Infections" ], "interventions": [ { "name": "Itraconazole", "type": "DRUG" }, { "name": "Flucytosine", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "Amphotericin B", "type": "DRUG" }, { "name": "Interferon gamma-1b", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InterMune", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 60, "start_date": "2000-01", "completion_date": "2001-07", "has_results": false, "last_update_posted_date": "2009-06-03", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 7, "location_summary": "Birmingham, Alabama • St Louis, Missouri • Camden, New Jersey + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Camden", "state": "New Jersey" }, { "city": "Newark", "state": "New Jersey" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00012467" }, { "nct_id": "NCT00002068", "title": "A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meningitis, Cryptococcal", "HIV Infections" ], "interventions": [ { "name": "Fluconazole", "type": "DRUG" }, { "name": "Amphotericin B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 7, "location_summary": "San Francisco, California • Wilmington, Delaware • Tampa, Florida + 4 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002068" }, { "nct_id": "NCT02971007", "title": "Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vulvovaginitis", "Yeast Infection", "Yeast Infection Vaginal", "Candidiasis, Vulvovaginal" ], "interventions": [ { "name": "Oral Encochleated Amphotericin B (CAMB)", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matinas BioPharma Nanotechnologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 137, "start_date": "2016-11", "completion_date": "2017-05", "has_results": true, "last_update_posted_date": "2018-11-02", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02971007" }, { "nct_id": "NCT00885703", "title": "High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cryptococcal Meningitis", "HIV Infections" ], "interventions": [ { "name": "Fluconazole", "type": "DRUG" }, { "name": "Amphotericin B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 168, "start_date": "2010-04-16", "completion_date": "2017-01-12", "has_results": true, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00885703" }, { "nct_id": "NCT00145249", "title": "Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cryptococcal Meningitis" ], "interventions": [ { "name": "Amphotericin B", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 143, "start_date": "2005-05", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2012-05-16", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00145249" }, { "nct_id": "NCT07743489", "title": "RB-PDT for Fusarium Keratitis: The LUMIERE Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fusarium Keratitis" ], "interventions": [ { "name": "Rose Bengal Photodynamic Therapy", "type": "DRUG" }, { "name": "Sham RB-PDT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 434, "start_date": "2027-01", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 2, "location_summary": "Palo Alto, California • Miami, Florida", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07743489" }, { "nct_id": "NCT02629419", "title": "CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Candidiasis, Chronic Mucocutaneous" ], "interventions": [ { "name": "Amphotericin B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matinas BioPharma Nanotechnologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 4, "start_date": "2016-09-27", "completion_date": "2022-08-06", "has_results": true, "last_update_posted_date": "2024-08-07", "last_synced_at": "2026-09-25T16:31:31.929Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02629419" } ] }